SCHEMBL4991850

SCHEMBL4991850

CCC1(I)C=CC=CC1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL808481 0.76 GRM6 (0.30)
SCHEMBL39621 0.76
SCHEMBL7569651 0.76
SCHEMBL7416135 0.76
SCHEMBL350505 0.75
SCHEMBL3022477 0.74
SCHEMBL8818307 0.74
SCHEMBL18091807 0.74
SCHEMBL6935722 0.74
SCHEMBL5546831 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9638690-B2 Compounds and compositions for use as alkylating agent sensors and methods of use thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-05-02 US disclosed
US-20160131641-A1 COMPOUNDS AND COMPOSITIONS FOR USE AS ALKYLATING AGENT SENSORS AND METHODS OF USE THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2016-05-12 US disclosed
US-7468378-B2 Substituted quinoline compounds PFIZER INC. (US) 2008-12-23 US disclosed
US-7393958-B2 Triamide-substituted heterobicyclic compounds PFIZER, INC. (US) 2008-07-01 US disclosed
US-7368573-B2 Triamide-substituted heterobicyclic compounds PFIZER INC. (US) 2008-05-06 US disclosed
US-20070093525-A1 Triamide-substituted heterobicyclic compounds PFIZER INC 2007-04-26 US disclosed
EP-1716137-A1 SUBSTITUTED QUINOLINE COMPOUNDS Pfizer Products Incorporated (US) 2006-11-02 EP disclosed
US-20060223851-A1 TRIAMIDE-SUBSTITUTED HETEROBICYCLIC COMPOUNDS BERTINATO PETER 2006-10-05 US disclosed
US-20060205751-A1 Novel compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-09-14 US disclosed
EP-1648885-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-04-26 EP disclosed
US-20050234099-A1 Substituted quinoline compounds PFIZER INC 2005-10-20 US disclosed
WO-2005080373-A1 SUBSTITUTED QUINOLINE COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-09-01 WO disclosed
WO-2005009993-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-03 WO disclosed
US-6153605-A Arylsecocholadiene derivatives HOFFMAN-LA ROCHE INC. (US) 2000-11-28 US disclosed
EP-0977734-A2 ARYLSECOCHOLADIENE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-02-09 EP disclosed
WO-1998047866-A2 ARYLSECOCHOLADIENE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1998-10-29 WO disclosed
WO-1995003700-A1 BRIDGED BIPHENYL CARBAPENEM ANTIBACTERIAL COMPOUNDS MERCK & CO., INC. (US) 1995-02-09 WO disclosed
WO-1995003699-A1 BRIDGED BIPHENYL CARBAPENEM COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 1995-02-09 WO disclosed
US-5374630-A Bridged carbapenem antibacterial compounds MERCK & CO., INC. (US) 1994-12-20 US disclosed
US-5372993-A Bridged carbapenem compounds, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 1994-12-13 US disclosed